Background The coronavirus disease 2019 seems to change antibiotic resistance pattern. Certain conditions in the Covid-19 era may be contributing to the rise of antimicrobial resistance (AMR). Due to the limited information on the impact of Covid-19 on antimicrobial resistance (AMR), the purpose of this research was to investigate the trend in antimicrobial resistance changes of E. coli, P. aeruginosa, K. pneumoniae, and A. baumannii in Hasheminezhad hospital. This hospital was a Corona center in Mashhad at the onset of this epidemic. Methods 1672 clinical samples were collected between January 21, 2020 and January 30, 2022from patients hospitalized at Hasheminezhad Hospital in Mashhad, Conventional microbiological procedures for identifying gram-negative bacteria and antibiotic susceptibility testing were used, according to the clinical and laboratory standards institute (CLSI) 2021. The two years of the pandemic, from the initial stage of the outbreak until the 6th peak, (January 2020 to and January 2022) were divided into 9 periods according to the seasons. Results Highest resistance rates were seen in E. coli (615 samples), K. pneumoniae (351 samples), P. aeruginosa (362 samples) and A. baumannii (344 samples) to Ampicillin (89.6%), Ampicillin (98%), Imipenem (91.8%), and Ceftazidime (94.6%), respectively. The largest change in antibiotic resistance was seen between Summer 2020 and Summer 2021 for K. pneumoniae with about a 30% rise in antibiotic resistance to Ceftriaxone. Conclusions All 4 species evaluated in this study, have shown rising AMR rates during the first year of the pandemic in the northeast of Iran. This study revealed that E. coli, P. aeruginosa, K. pneumoniae, and A. baumannii strains in Northern Iran have a higher level of antibiotic resistance than what was measured in similar studies conducted before the pandemic. This will further restrict treatment choices and jeopardize global public health.
Context: Coronavirus disease 2019 (COVID-19) and the infection control strategies have affected breastfeeding and mother-newborn contact due to the fear of disease transmission to the baby. Objectives: This study aimed to evaluate the possibility of CPVID-19 transmission by reviewing the currently published articles. Methods: In this systematic review, 296 articles were first retrieved from IranMedex, SID, IranDoc, Magiran, Iranian Registry of Clinical Trials (IRCT), PubMed, ProQuest, Scopus, Science Direct, Medline, and Google Scholar search engine using the keywords "breastfeeding", "breast", "vertical transfer", "breast milk", "colostrum", "corona", and "COVID-19". Of the 296 retrieved articles, 16 were eligible for the review. Results: Reviewed articles included four retrospective cross-sectional studies, one cohort study, eight case reports, and three case series. Overall, the studies reported 237 RT-PCR tests on breast milk and/or nasopharyngeal or oropharyngeal swabs from mother or baby, and 156 serum antibody measurements in mother or baby. The overall findings indicated a low risk for COVID-19 transmission from mother to infant through breastfeeding, while breastfeeding was detected to transfer the antibodies to the newborn. Conclusions: Due to the low transmission risk, it was recommended that mothers with mild to moderate symptoms should breastfeed their infants with infection control measurements, while mothers with severe symptoms should use pumped breastmilk for feeding their infants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.